Christophe Marchand
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents
Papers in
- Virology 51
- HIV Research and Treatment 51
- Toxicology 14
- Bioactive Compounds and Antitumor Agents 14
- Co-authors
- Yves PommierHongliang ZhangElisabetta LeoAllison A. JohnsonStéphane D. LemaireMirko ZaffagniniPaolo TrostTerrence R. Burke
- Journals
- Journal of Medicinal Chemistry (26 papers)Journal of Biological Chemistry (16 papers)Bioorganic & Medicinal Chemistry Letters (10 papers)Molecular Pharmacology (5 papers)PLANT PHYSIOLOGY (5 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Christophe Marchand
178 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Virology 2.2k
- Toxicology 693
- Infectious Diseases 2.6k
- Molecular Biology 7.8k
- Organic Chemistry 2.2k
Countries citing papers authored by Christophe Marchand
This map shows the geographic impact of Christophe Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Marchand more than expected).
Fields of papers citing papers by Christophe Marchand
This network shows the impact of papers produced by Christophe Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Marchand. The network helps show where Christophe Marchand may publish in the future.
Co-authors
The 25 scholars most cited alongside Christophe Marchand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 11 | |
| 8 | 2019 | 38 | |
| 9 | 2019 | 20 | |
| 10 | 2018 | 85 | |
| 11 | 2016 | 58 | |
| 12 | 2014 | 17 | |
| 13 | 2009 | 68 | |
| 14 | 2009 | 78 | |
| 15 | 2009 | 45 | |
| 16 | 2007 | 17 | |
| 17 | 2006 | 50 | |
| 18 | 2002 | 48 | |
| 19 | 2002 | 91 | |
| 20 | 2000 | 34 |
About Christophe Marchand
Christophe Marchand is a scholar working on Virology, Toxicology, Infectious Diseases, Molecular Biology and Molecular Medicine, having authored 179 papers that have together received 11.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (67 papers), HIV Research and Treatment (51 papers), Biochemical and Molecular Research (45 papers), Cancer therapeutics and mechanisms (45 papers), Redox biology and oxidative stress (27 papers), DNA and Nucleic Acid Chemistry (17 papers), Synthesis and Biological Evaluation (16 papers) and Bioactive Compounds and Antitumor Agents (14 papers). The work is most often cited by research in Virology (2.2k citations), Toxicology (693 citations), Infectious Diseases (2.6k citations), Molecular Biology (7.8k citations) and Organic Chemistry (2.2k citations). Christophe Marchand has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Yves Pommier, Hongliang Zhang, Elisabetta Leo, Allison A. Johnson, Stéphane D. Lemaire, Mirko Zaffagnini, Paolo Trost, Terrence R. Burke, Paulette Decottignies and Mathieu Métifiot. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Molecular Pharmacology and PLANT PHYSIOLOGY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.